Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
AstraZeneca PLC

AstraZeneca PLC (AZN) Stock Overview

Explore AstraZeneca PLC’s financial performance, market position, analyst ratings, and future outlook.

AZN●NYSE
HealthcareDrug Manufacturers - General
$161.91
$0.49(0.30%)
U.S. Market opens in 1h 31m

AstraZeneca PLC (AZN)

Meyka AI Score

Z

Key Financials

Market Cap251.1B
P/E Ratio24.00
EPS (TTM)$9.26
ROE0.22%
Fundamental Analysis

AI Price Forecasts

1 Month$180.55
3 Months$213.74
1 Year Target$158.37

AZN Stock Analysis & Investment Overview (NYSE)

Our AI-powered analysis of AstraZeneca PLC (NYSE: AZN) gives investors deep insight into how the stock performs on the NYSE exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, AstraZeneca PLC's NYSE-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of AZN on the NYSE shows an RSI of 39.81, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $158.37 for the NYSE listing.

Key metrics behind AstraZeneca PLC's NYSE-traded stock include a P/E ratio of 24.00 and a market capitalization of 251.1B. Combined with our AI analysis, these give both institutional and retail investors a clear view of AZN on the NYSE.

Price Performance (NYSE: AZN)

1-Day Change
0.29%
5-Day Change
-1.16%
1-Month Change
-5.66%
3-Month Change
-11.46%
6-Month Change
-16.16%
Year-to-Date (YTD) Change
-7.75%
1-Year Change
10.79%
3-Year Change
17.35%
5-Year Change
42.11%
All-Time (Max) Change
1506.05%

Contact Information

https://www.astrazeneca.com
44 20 3749 5000
1 Francis Crick Avenue, Cambridge, CA, CB2 0AA

Company Facts

961,000 Employees
IPO DateMay 12, 1993
CountryGB
Actively Trading

Frequently Asked Questions